These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 34266345

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.
    Liu J, Xing Y, Rong L.
    Oncol Rep; 2018 Apr; 39(4):1631-1639. PubMed ID: 29484437
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.
    Song L, Li D, Gu Y, Wen ZM, Jie J, Zhao D, Peng LP.
    Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.
    Li H, Huhe M, Lou J.
    Biomed Res Int; 2021 Sep; 2021():7590976. PubMed ID: 34307670
    [Abstract] [Full Text] [Related]

  • 10. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.
    Xing S, Qu Y, Li C, Huang A, Tong S, Wu C, Fan K.
    J Cell Physiol; 2019 Dec; 234(12):22657-22665. PubMed ID: 31111480
    [Abstract] [Full Text] [Related]

  • 11. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 Dec; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 12. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.
    Zhao M, Xu P, Liu Z, Zhen Y, Chen Y, Liu Y, Fu Q, Deng X, Liang Z, Li Y, Lin X, Fang W.
    Cell Death Dis; 2018 Jan 23; 9(2):78. PubMed ID: 29362431
    [Abstract] [Full Text] [Related]

  • 13. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y, Zhao L, Li Q, Xi C, Li Y, Li Z.
    Thorac Cancer; 2020 Aug 23; 11(8):2196-2208. PubMed ID: 32602212
    [Abstract] [Full Text] [Related]

  • 14. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9.
    Liu B, Wang R, Liu H.
    Biomed Res Int; 2021 Aug 23; 2021():6622342. PubMed ID: 34055989
    [Abstract] [Full Text] [Related]

  • 15. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
    Zhao W, Sun Q, Yu Z, Mao S, Jin Y, Li J, Jiang Z, Zhang Y, Chen M, Chen P, Chen D, Xu H, Ding S, Yu Z.
    Gene; 2018 Sep 05; 670():31-37. PubMed ID: 29803922
    [Abstract] [Full Text] [Related]

  • 16. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
    Chen Y, Liao W, Yuan A, Xu H, Yuan R, Cao J.
    Panminerva Med; 2022 Sep 05; 64(3):374-383. PubMed ID: 32506887
    [Abstract] [Full Text] [Related]

  • 17. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB, Wang SX.
    Eur Rev Med Pharmacol Sci; 2019 Feb 05; 23(3):1093-1101. PubMed ID: 30779077
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.
    Zhao G, Cai C, Yang T, Qiu X, Liao B, Li W, Ji Z, Zhao J, Zhao H, Guo M, Ma Q, Xiao C, Fan Q, Ma B.
    PLoS One; 2013 Feb 05; 8(1):e53906. PubMed ID: 23372675
    [Abstract] [Full Text] [Related]

  • 19. MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway.
    Sun DM, Tang BF, Li ZX, Guo HB, Cheng JL, Song PP, Zhao X.
    Sci Rep; 2018 May 22; 8(1):8007. PubMed ID: 29789623
    [Abstract] [Full Text] [Related]

  • 20. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB, Zhang WP, Shi JL, Wang JW.
    Eur Rev Med Pharmacol Sci; 2018 Jun 22; 22(11):3408-3414. PubMed ID: 29917192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.